AIX-EN-PROVENCE, FRANCE--(Marketwired - Apr 15, 2015) - SuperSonic Imagine (EURONEXT PARIS: SSI) (Euronext: SSI, FR0010526814), the highly innovative ultrasound company that pioneered breakthrough ShearWave™ Elastography technology (SWE™) and UltraFast™ Doppler, was a key focus of interest at this year's American Institute of Ultrasound in Medicine (AIUM) in Orlando, Florida in March.

SuperSonic Imagine's Aixplorer ultrasound system was demonstrated in heavily attended sessions. Clinicians from around the world participated in hands-on workshops highlighting the wide range of Aixplorer's clinical applications including vascular, pediatric, musculoskeletal and general imaging as well as biopsy guidance. Aixplorer surpasses the limits of traditional ultrasound with its unique UltraFast software-based platform. The speed of UltraFast enables the Company's proprietary ShearWave Elastography technology to assess and quantify tissue stiffness in real time. Tissue stiffness is used by physicians to help identify potentially malignant or other diseased tissue.

In addition to ShearWave Elastography, the software technology platform also enables Aixplorer's UltraFast Doppler. Conventional Doppler ultrasound requires two separate exams for imaging and measurement. UltraFast combines Color Flow Imaging and Pulsed Wave Doppler into one simple exam, providing physicians exam results simultaneously and helping to increase patient throughput.

"We are very pleased to have played an integral role in this year's AIUM/WFUMB conference both in terms of clinical education and raising awareness of Aixplorer's versatility and sophistication. It is becoming increasingly clear that SuperSonic Imagine's technology provides significant clinical benefits to physicians and patients," commented Alex Exposito, SuperSonic Imagine's Director of North America.

Since its market introduction in 2009, Aixplorer has continued to evolve to become a fully featured diagnostic ultrasound system, including applications such as breast, abdomen, musculoskeletal, prostate, small parts, OB/GYN, vascular, and pediatrics.

About SuperSonic Imagine

Founded in 2005 and based in Aix-en-Provence (France), SuperSonic Imagine is a company specializing in medical imaging. The company designs, develops and markets a revolutionary ultrasound system, Aixplorer®, with an UltraFast™ platform that can acquire images 200 times faster than conventional ultrasound systems. Aixplorer is the only system that can image two types of waves: ultrasound waves ensure excellent image quality and shear waves, which allow physicians to visualize and analyze the stiffness of tissue in a real-time, reliable, reproducible and non-invasive manner. This innovation, ShearWave™Elastography, significantly improves the detection and characterization of numerous pathologies in several applications including breast, thyroid, liver and prostate. SuperSonic Imagine has been granted regulatory clearances for the commercialization of Aixplorer in the main global markets. Over the past years, SuperSonic Imagine enjoyed the backing of several prestigious investors, among which Auriga Partners, Edmond de Rothschild Investment Partners, Bpifrance, Omnes Capital and NBGI.

For more information about SuperSonic Imagine, please go to

Contact Information:

Contact information:

SuperSonic Imagine
Marketing & Communication
Emmanuelle Vella
04 86 79 03 27

Investor Relations - EU
Pierre Laurent / Florent Alba
+33 1 44 71 98 55

Blueprint Life Science Group
Investor Relations - US
Candice Knoll
415 375 3340 Ext. 105

Media Relations
Florence Portejoie
+33 1 58 18 32 58 - +33 6 88 84 81 74
Adelaide Manester
+33 1 58 18 32 58 - +33 6 70 45 74 37